Cover Image
Saved in:

Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.

Bibliographic Details
Corporate Author: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Format: Government Document Online Book
Language:English
Published: Washington : U.S. G.P.O., 2008.
Series:S. hrg. ; 110-375
Subjects:
Online Access:ONLINE VERSION
ONLINE VERSION
Tags: Add Tag
No Tags, Be the first to tag this record!